Novo Nordisk Market Cap 2006-2019 | NVO

Novo Nordisk market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Novo Nordisk market cap as of March 27, 2020 is $134.41B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $134.408B $18.296B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $333.683B 14.58
Roche Holding AG (RHHBY) Switzerland $265.584B 0.00
Merck (MRK) United States $186.492B 14.17
Novartis AG (NVS) Switzerland $182.748B 15.22
Pfizer (PFE) United States $176.138B 10.76
Eli Lilly (LLY) United States $128.578B 22.24
Bristol-Myers Squibb (BMY) United States $117.955B 11.19
AstraZeneca (AZN) United Kingdom $111.168B 23.93
AbbVie (ABBV) United States $109.023B 8.26
Sanofi (SNY) France $107.553B 12.78
GlaxoSmithKline (GSK) United Kingdom $92.949B 11.79
Bayer (BAYRY) Germany $53.155B 7.66
H Lundbeck (HLUYY) Denmark $5.819B 10.11